India's Ranbaxy settled a major patent dispute Wednesday with rival Pfizer over the launch of a generic version of Ranbaxy's key cholesterol...

The move will give Ranbaxy access to over $1 billion in sales revenue.

10515

Ranbaxy has reached a settlement with Pfizer on Lipitor litigation. Ranbaxy and Pfizer have also agreed to settle Caduet and Quinapril cases. Both the pharma majors have agreed to withdraw all ...

...uation post settlement whether Pfizer is going to go ahead or not with its counter offer and then take a call on whether one wants to jump in the fray and buy Ranbaxy at Rs 620 plus because of Lipitor

89

...cholesterol-fighting drug, Lipitor, which is also among the world s highest selling drug.The value accruing to Ranbaxy is seen exceeding $1.5 billion, say sources. This is also one of the biggest ...